APLS

NASDAQStock

Apellis Pharmaceuticals, Inc.

$18.69+0.30 (+1.63%)

52-Week Range

$16.36

$30.05

Key Stats

Market Cap

2.4B

P/E Ratio

60.29

Dividend Yield

—

Beta

0.29

Volume

785.7K

Avg Volume

2.0M

Performance

-16.60%

-25.12%

-24.60%

YTD

-28.89%

-25.43%

-71.94%

-60.96%

Price Chart

ETF Exposure

APLS is held by 133 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SPHC.MI	Amundi Core S&P 500 Swap UCITS ETF EUR Hedged Acc	0.00%	25,801	$425K	$23.80B	0.07%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	1,415	$32K	$1.46B	0.24%
V3AM.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	1,415	$24K	$1.09B	0.24%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	5,963	$182K	$12.17B	0.24%
VT	Vanguard Total World Stock ETF	0.00%	76,896	$1.7M	$80.60B	0.06%
ZPRV.DE	State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF	0.00%	933	$14K	$757.5M	0.30%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	2,297	$45K	$2.84B	0.19%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	2,001	$39K	$3.23B	0.20%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	29,825	$548K	$40.55B	0.17%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	47	$901	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	54	$1K	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	48	$933	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	50	$965	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	38	$742	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	26	$496	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	19	$375	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	9	$166	$9.3M	0.12%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	450	$8K	$1.43B	0.09%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	167	$5K	$820.6M	0.25%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	140,268	$213K	$14.63B	0.20%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	226	$4K	$725.0M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	693	$13K	$1.67B	0.20%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	189	$4K	$803.1M	0.23%
IMID.L	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	800	$17K	$5.16B	0.17%
IRTR	iShares LifePath Retirement ETF	0.00%	20	$390	$51.7M	0.08%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	29	$564	$60.6M	0.09%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	2,281	$45K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	2,281	$45K	$6.3M	0.60%
SPYI.DE	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	800	$15K	$4.48B	0.17%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	2,281	$45K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	2,281	$45K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	2,281	$45K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	28	$882	$337.7M	0.32%

PreviousPage 3 of 3

About APLS ETF Exposure

Apellis Pharmaceuticals, Inc. (APLS) is held by 133 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, APLS is a widely held institutional stock. The stock currently trades at $18.69. Investors can gain exposure to APLS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold APLS, sorted by portfolio weight.